Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

drug response

  • Open Access
    Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug Resistance
    AMBER XINYU LI, JIMMY JIANYUAN ZENG, ELYAS KHAN, Q. PING DOU, XINGUO ZHUANG, EDISON KE JI, FIONA RUGE, TRACEY A. MARTIN, SHUQIN JIA and WEN G. JIANG
    Cancer Genomics & Proteomics January 2024, 21 (1) 30-40; DOI: https://doi.org/10.21873/cgp.20427
  • Open Access
    Pan-cancer Analysis Reveals Cancer-dependent Expression of SOX17 and Associated Clinical Outcomes
    LI XU, YOUHUANG BAI, YIHANG CHENG, XIUJIE SHENG and DEQIANG SUN
    Cancer Genomics & Proteomics September 2023, 20 (5) 433-447; DOI: https://doi.org/10.21873/cgp.20395
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire